Vision impairment in middle-aged women tied to later depression
Nov 03, 2021
The authors call for early identification and timely correction of vision problems among women at midlife to help maintain good mental health.
Mirtazapine does not reduce agitation in dementia patients
Nov 03, 2021
In a randomized, double-blind trial, no difference was seen in scores for agitated behaviors at 12 weeks with mirtazapine versus placebo.
Outpatient care has shifted toward more specialist care for Medicare recipients
Nov 01, 2021
“We find that during the past 20 years, healthcare for Medicare beneficiaries is increasingly fragmented across several physicians, mostly specialists, with little change in annual engagement with...
Fully vaccinated with breakthrough infection can transmit COVID-19
Nov 01, 2021
The peak viral load was similar for fully vaccinated and unvaccinated index cases; the viral load declines at faster rate among fully vaccinated individuals.
Higher dose of steroid does not improve outcomes in severe COVID-19
Oct 29, 2021
The number of days alive without life support at day 28 did not differ with dexamethasone 12 mg versus 6 mg in those with severe hypoxemia.
Itepekimab bests placebo for moderate-to-severe asthma
Oct 28, 2021
The incidence of events indicating a loss of asthma control was lower with itepekimab monotherapy in a phase 2, proof-of-concept trial.
Cost-sharing waivers did not cover all COVID-19 hospital care in 2020
Oct 27, 2021
The researchers found that 71.2% of privately insured patients and 49.1% of Medicare Advantage patients had cost sharing for any hospitalization-related service, including those billed by clinicians.
White House takes more steps to up supply of rapid at-home COVID-19 tests
Oct 26, 2021
Tests will be be particularly useful during flu season because the tests can help distinguish between the flu and COVID-19.
>86 percent of U.S. adults exceed CDRR sodium intake goal
Oct 22, 2021
After adjustment for energy intake, a significant change in usual sodium intake was only observed for adults aged 71 years or older and Mexican American adults.
mRNA Vaccine more effective booster to ChAdOx1 nCoV-19
Oct 22, 2021
“Our study shows a greater risk reduction for people who received an mRNA vaccine after having received a first dose of a vector-based, as compared to people having received the vector-based vaccine...